OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Orbitrap Fusion Lumos
(1)
Publication Date
2023
(1)
Release Date
2024
(2)
2019
(2)
2014
(2)
2023
(1)
2022
(1)
2018
(1)
2017
(1)
2015
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care.
Not available
S-EPMC5241219
|
biostudies-literature
Cite
Characterization of kidney CD45intCD11bintF4/80+MHCII+CX3CR1+Ly6C- "intermediate mononuclear phagocytic cells".
Not available
S-EPMC5983557
|
biostudies-literature
Cite
Morbidity of urologic surgical procedures: an analysis of rates, risk factors, and outcomes.
Not available
S-EPMC4349385
|
biostudies-literature
Cite
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Not available
S-EPMC4352319
|
biostudies-literature
Cite
Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma.
Not available
S-EPMC9638762
|
biostudies-literature
Cite
Very-high-risk localized prostate cancer: definition and outcomes.
Not available
S-EPMC3945953
|
biostudies-literature
Cite
The national utilization of nonoperative management for small renal masses over 10 years.
Not available
S-EPMC10640883
|
biostudies-literature
Cite
Rate of benign histology after resection of suspected renal cell carcinoma: multicenter comparison between Korea and the United States.
Not available
S-EPMC10870474
|
biostudies-literature
Cite
Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
Not available
S-EPMC7029397
|
biostudies-literature
Cite
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
Not available
S-EPMC11323681
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets